TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Role of Virtual Therapy by Means of Reinforced Feedback in Virtual Environment on Upper Limb Function in Post-stroke Patients.
Brief Summary: The aims of the study is to explore whether the rehabilitation of the upper extremity performed in interaction with a virtual environment could improve motor function in post-ischemic and post-haemorrhagic stroke subjects with hemiparesis, in comparison to the traditional neuromotor rehabilitation treatment.


Options:
A: Arm Label: Nintendo Wii FitTM; Type: EXPERIMENTAL; Interventions: Other: Wii Fit | Arm Label: Lower extremity exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: Lower Extremity Exercise | Intervention Type: OTHER; Name: Wii Fit; Assigned to Arm(s): Nintendo Wii FitTM | Intervention Type: OTHER; Name: Lower Extremity Exercise; Assigned to Arm(s): Lower extremity exercise
B: Arm Label: Reinforced Feedback in Virtual Environment; Type: EXPERIMENTAL; Interventions: Device: Reinforced Feedback in Virtual Environment (RFVE) | Arm Label: Traditional Neromotor Rehabilitation; Type: OTHER; Interventions: Other: Traditional Neuromotor Rehabilitation | Intervention Type: DEVICE; Name: Reinforced Feedback in Virtual Environment (RFVE); Assigned to Arm(s): Reinforced Feedback in Virtual Environment | Intervention Type: OTHER; Name: Traditional Neuromotor Rehabilitation; Assigned to Arm(s): Traditional Neromotor Rehabilitation
C: Arm Label: E-glove system; Type: EXPERIMENTAL; Interventions: Device: E-glove system | Arm Label: Conventional occupational therapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional occupational therapy | Intervention Type: DEVICE; Name: E-glove system; Assigned to Arm(s): E-glove system | Intervention Type: PROCEDURE; Name: Conventional occupational therapy; Assigned to Arm(s): Conventional occupational therapy
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: LapSimGyn training until expert proficiency level is reached | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Traditional clinical education | Intervention Type: BEHAVIORAL; Name: LapSimGyn training until expert proficiency level is reached; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Traditional clinical education; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme
Brief Summary: This trial investigates the effects of FE 999049 compared to GONAL-F.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Follitropin Delta (FE 999049) | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin Alfa (GONAL-F) | Intervention Type: DRUG; Name: Follitropin Delta (FE 999049); Assigned to Arm(s): A | Intervention Type: DRUG; Name: Follitropin Alfa (GONAL-F); Assigned to Arm(s): B
B: Arm Label: Highly Purified Menotrophin; Type: EXPERIMENTAL; Interventions: Drug: Highly purified menotrophin | Arm Label: Recombinant FSH; Type: ACTIVE_COMPARATOR; Interventions: Drug: Recombinant FSH | Intervention Type: DRUG; Name: Highly purified menotrophin; Assigned to Arm(s): Highly Purified Menotrophin | Intervention Type: DRUG; Name: Recombinant FSH; Assigned to Arm(s): Recombinant FSH
C: Arm Label: AMH-group; Type: EXPERIMENTAL; Interventions: Other: AMH-analysis | Arm Label: Non-AMH-group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: AMH-analysis; Assigned to Arm(s): AMH-group
D: Arm Label: FE 999049 6 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: FE 999049 9 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: FE 999049 12 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: FOLLISTIM 150 IU; Type: ACTIVE_COMPARATOR; Interventions: Drug: follitropin beta | Intervention Type: DRUG; Name: FE 999049; Assigned to Arm(s): FE 999049 12 µg, FE 999049 6 µg, FE 999049 9 µg | Intervention Type: DRUG; Name: follitropin beta; Assigned to Arm(s): FOLLISTIM 150 IU

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme
Brief Summary: This trial investigates the effects of FE 999049 compared to GONAL-F.


Options:
A: Arm Label: Highly Purified Menotrophin; Type: EXPERIMENTAL; Interventions: Drug: Highly purified menotrophin | Arm Label: Recombinant FSH; Type: ACTIVE_COMPARATOR; Interventions: Drug: Recombinant FSH | Intervention Type: DRUG; Name: Highly purified menotrophin; Assigned to Arm(s): Highly Purified Menotrophin | Intervention Type: DRUG; Name: Recombinant FSH; Assigned to Arm(s): Recombinant FSH
B: Arm Label: 5.2 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 6.9 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 8.6 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 10.3 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 12.1 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 11 µg FbM (150 IU); Type: ACTIVE_COMPARATOR; Interventions: Drug: Gonal - F | Intervention Type: DRUG; Name: FE 999049; Assigned to Arm(s): 10.3 µg, 12.1 µg, 5.2 µg, 6.9 µg, 8.6 µg | Intervention Type: DRUG; Name: Gonal - F; Assigned to Arm(s): 11 µg FbM (150 IU)
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Follitropin Delta (FE 999049) | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin Alfa (GONAL-F) | Intervention Type: DRUG; Name: Follitropin Delta (FE 999049); Assigned to Arm(s): A | Intervention Type: DRUG; Name: Follitropin Alfa (GONAL-F); Assigned to Arm(s): B
D: Arm Label: 450 IU daily dose of gonadotrophin; Type: ACTIVE_COMPARATOR; Interventions: Drug: menotropins for injection, Drug: urofollitropin for injection | Arm Label: 600 IU daily dose of gonadotrophin; Type: EXPERIMENTAL; Interventions: Drug: menotropins for injection, Drug: urofollitropin for injection | Intervention Type: DRUG; Name: menotropins for injection; Assigned to Arm(s): 450 IU daily dose of gonadotrophin, 600 IU daily dose of gonadotrophin | Intervention Type: DRUG; Name: urofollitropin for injection; Assigned to Arm(s): 450 IU daily dose of gonadotrophin, 600 IU daily dose of gonadotrophin

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Evaluating the Immunogenicity of FE 999049 in Repeated Cycles of Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme
Brief Summary: This trial investigates the immunogenicity of FE 999049 in repeated cycles.


Options:
A: Arm Label: Flare Up; Type: ACTIVE_COMPARATOR; Interventions: Drug: Flare up | Arm Label: Microdose GnRh; Type: EXPERIMENTAL; Interventions: Drug: Microdose GnRh | Intervention Type: DRUG; Name: Microdose GnRh; Assigned to Arm(s): Microdose GnRh | Intervention Type: DRUG; Name: Flare up; Assigned to Arm(s): Flare Up
B: Arm Label: Follitropin delta; Type: EXPERIMENTAL; Interventions: Drug: Follitropin delta | Arm Label: Gonal-F; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin alfa | Intervention Type: DRUG; Name: Follitropin alfa; Assigned to Arm(s): Gonal-F | Intervention Type: DRUG; Name: Follitropin delta; Assigned to Arm(s): Follitropin delta
C: Arm Label: FE 999049 6 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: FE 999049 9 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: FE 999049 12 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: FOLLISTIM 150 IU; Type: ACTIVE_COMPARATOR; Interventions: Drug: follitropin beta | Intervention Type: DRUG; Name: FE 999049; Assigned to Arm(s): FE 999049 12 µg, FE 999049 6 µg, FE 999049 9 µg | Intervention Type: DRUG; Name: follitropin beta; Assigned to Arm(s): FOLLISTIM 150 IU
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Follitropin Delta (FE 999049) | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin Alfa (GONAL-F) | Arm Label: C; Type: EXPERIMENTAL; Interventions: Drug: Follitropin Delta (FE 999049) | Arm Label: D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin Alfa (GONAL-F) | Intervention Type: DRUG; Name: Follitropin Delta (FE 999049); Assigned to Arm(s): A, C | Intervention Type: DRUG; Name: Follitropin Alfa (GONAL-F); Assigned to Arm(s): B, D

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior
Brief Summary: Falls are a serious health concern for persons with multiple sclerosis (MS). Over 50% of persons with MS suffer a fall over a 6-month periodwith the majority of falls resulting in medical attention for injuries (i.e., lacerations, bone fractures, \& head injuries). The effects of a fall are often compounded as it can lead to activity curtailment, physiological deconditioning, and institutionalization. Despite the importance of falls in persons with MS, the appropriate prevention strategies (i.e. rehabilitation approaches) are not clear. The purpose of this investigation is to determine whether exercise based or educational based interventions are more suited for fall prevention in older adults with MS.


Options:
A: Arm Label: Free From Falls; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Free From Falls Online | Arm Label: Waitlist; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Waitlist Control | Intervention Type: BEHAVIORAL; Name: Free From Falls Online; Assigned to Arm(s): Free From Falls | Intervention Type: BEHAVIORAL; Name: Waitlist Control; Assigned to Arm(s): Waitlist
B: Arm Label: Home-based Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based exercise | Arm Label: Education; Type: EXPERIMENTAL; Interventions: Behavioral: Education | Arm Label: Exercise plus education; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise plus Education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home-based exercise; Assigned to Arm(s): Home-based Exercise | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education | Intervention Type: BEHAVIORAL; Name: Exercise plus Education; Assigned to Arm(s): Exercise plus education
C: Arm Label: Training group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Assistive Device Training | Arm Label: Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Assistive Device Training; Assigned to Arm(s): Training group
D: Arm Label: Sensory-motor Integration Training; Type: EXPERIMENTAL; Interventions: Procedure: Sensory-motor Integration Training | Arm Label: Conventional neurorehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional neurorehabilitation treatment | Intervention Type: PROCEDURE; Name: Sensory-motor Integration Training; Assigned to Arm(s): Sensory-motor Integration Training | Intervention Type: PROCEDURE; Name: Conventional neurorehabilitation treatment; Assigned to Arm(s): Conventional neurorehabilitation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior
Brief Summary: Falls are a serious health concern for persons with multiple sclerosis (MS). Over 50% of persons with MS suffer a fall over a 6-month periodwith the majority of falls resulting in medical attention for injuries (i.e., lacerations, bone fractures, \& head injuries). The effects of a fall are often compounded as it can lead to activity curtailment, physiological deconditioning, and institutionalization. Despite the importance of falls in persons with MS, the appropriate prevention strategies (i.e. rehabilitation approaches) are not clear. The purpose of this investigation is to determine whether exercise based or educational based interventions are more suited for fall prevention in older adults with MS.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treated group; Type: EXPERIMENTAL; Interventions: Other: Telephone support, telemonitoring and tele-exercise | Intervention Type: OTHER; Name: Telephone support, telemonitoring and tele-exercise; Assigned to Arm(s): Treated group
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Other: Interdisciplinary intervention program | Intervention Type: OTHER; Name: Interdisciplinary intervention program; Assigned to Arm(s): Experimental group
C: Arm Label: Home-based Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based exercise | Arm Label: Education; Type: EXPERIMENTAL; Interventions: Behavioral: Education | Arm Label: Exercise plus education; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise plus Education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home-based exercise; Assigned to Arm(s): Home-based Exercise | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education | Intervention Type: BEHAVIORAL; Name: Exercise plus Education; Assigned to Arm(s): Exercise plus education
D: Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Arm Label: Multifactorial Falls Prevention Program; Type: EXPERIMENTAL; Interventions: Other: On-site exercise, Other: home-based exercise, Other: Educational and behavioural, Other: Management of modifiable risk factors | Intervention Type: OTHER; Name: On-site exercise; Assigned to Arm(s): Multifactorial Falls Prevention Program | Intervention Type: OTHER; Name: home-based exercise; Assigned to Arm(s): Multifactorial Falls Prevention Program | Intervention Type: OTHER; Name: Educational and behavioural; Assigned to Arm(s): Multifactorial Falls Prevention Program | Intervention Type: OTHER; Name: Management of modifiable risk factors; Assigned to Arm(s): Multifactorial Falls Prevention Program | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): usual care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Crenobalneotherapy in the Treatment of Chronic Venous Insufficiency. A Randomized Clinical Trial.
Brief Summary: At 3 months, crenobalneotherapy session is superior to waiting list for patients with chronic venous insufficiency.


Options:
A: Arm Label: Crenobalneotherapy; Type: EXPERIMENTAL; Interventions: Behavioral: Crenobalneotherapy | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Crenobalneotherapy; Assigned to Arm(s): Crenobalneotherapy
B: Arm Label: Immediate SPA treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Immediate spa treatment | Arm Label: Late SPA treatment; Type: SHAM_COMPARATOR; Interventions: Drug: Late spa treatment | Intervention Type: DRUG; Name: Immediate spa treatment; Assigned to Arm(s): Immediate SPA treatment | Intervention Type: DRUG; Name: Late spa treatment; Assigned to Arm(s): Late SPA treatment
C: Arm Label: İnspiratory muscle training group; Type: EXPERIMENTAL; Interventions: Other: exercise therapy | Arm Label: Calf muscle training group; Type: EXPERIMENTAL; Interventions: Other: exercise therapy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: exercise therapy; Assigned to Arm(s): Calf muscle training group, İnspiratory muscle training group
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Fitbit, Behavioral: 30-minute education session | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 30-minute education session | Intervention Type: DEVICE; Name: Fitbit; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: 30-minute education session; Assigned to Arm(s): Control, Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase II - Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult Male Circumcision Programs in Zimbabwe (Comparative Study)
Brief Summary: The protocol, approved by the Medical Research Council, was issued to assess the safety and efficacy of the non-surgical device for applying it to the national scale up of adult male circumcision in Zimbabwe


Options:
A: Arm Label: Unicirc with tissue adhesive; Type: EXPERIMENTAL; Interventions: Procedure: Unicirc with tissue adhesive | Arm Label: Open Surgical; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Surgical | Intervention Type: PROCEDURE; Name: Unicirc with tissue adhesive; Assigned to Arm(s): Unicirc with tissue adhesive | Intervention Type: PROCEDURE; Name: Open Surgical; Assigned to Arm(s): Open Surgical
B: Arm Label: PrePex™ device; Type: EXPERIMENTAL; Interventions: Device: PrePex™ device for adult male circumcision | Arm Label: Surgical; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surgical circumcision | Intervention Type: DEVICE; Name: PrePex™ device for adult male circumcision; Assigned to Arm(s): PrePex™ device | Intervention Type: PROCEDURE; Name: Surgical circumcision; Assigned to Arm(s): Surgical
C: Arm Label: PrePex™; Type: EXPERIMENTAL; Interventions: Device: PrePex™ device for adult male circumcision | Arm Label: Surgical; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surgical circumcision | Intervention Type: DEVICE; Name: PrePex™ device for adult male circumcision; Assigned to Arm(s): PrePex™ | Intervention Type: PROCEDURE; Name: Surgical circumcision; Assigned to Arm(s): Surgical
D: Intervention Type: PROCEDURE; Name: Adult male circumcision; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Purpose and rationale: Acute pulmonary embolism (PE) is a common and often fatal disease, with an approximately 30% mortality rate without treatment. Treatment is important to reduce mortality and recurrence in acute PE. Therapeutic options for PE include subcutaneous low molecular weight heparin (SC LMWH), intravenous unfractionated heparin (IV UFH), subcutaneous unfractionated heparin and subcutaneous fondaparinux with or without thrombolysis. In the treatment of acute PE, SC LMWH has been shown, at least, as effective and safe as IV UFH \[4\]. Compared to IV UFH, SC LMWH associated with lower mortality, fewer recurrent thrombotic events and less major bleeding. Current guidelines recommend use of SC LMWH for most hemodynamically stable patients with PE and they say that SC LMWH have not been tested in the setting of acute massive PE.

The purpose of this study is to demonstrate that SC LMWH is as safe as IV UFH in the treatment of acute PE in combination with thrombolytic treatment.


Options:
A: Arm Label: Fondaparinux; Type: EXPERIMENTAL; Interventions: Drug: Fondaparinux sodium | Arm Label: unfractionated heparin; Type: OTHER; Interventions: Drug: unfractionated heparin (UFH) | Intervention Type: DRUG; Name: Fondaparinux sodium; Assigned to Arm(s): Fondaparinux | Intervention Type: DRUG; Name: unfractionated heparin (UFH); Assigned to Arm(s): unfractionated heparin
B: Arm Label: Fondaparinux; Type: EXPERIMENTAL; Interventions: Drug: Fondaparinux sodium | Arm Label: unfractionated heparin; Type: OTHER; Interventions: Drug: unfractionated heparin (UFH) | Intervention Type: DRUG; Name: Fondaparinux sodium; Assigned to Arm(s): Fondaparinux | Intervention Type: DRUG; Name: unfractionated heparin (UFH); Assigned to Arm(s): unfractionated heparin
C: Arm Label: enoxaparin and alteplase; Type: ACTIVE_COMPARATOR; Interventions: Drug: enoxaparin ,alteplase, unfractionated heparin | Arm Label: Unfractionated heparin and alteplase; Type: ACTIVE_COMPARATOR; Interventions: Drug: enoxaparin ,alteplase, unfractionated heparin | Intervention Type: DRUG; Name: enoxaparin ,alteplase, unfractionated heparin; Assigned to Arm(s): Unfractionated heparin and alteplase, enoxaparin and alteplase
D: Intervention Type: DRUG; Name: UFH 250 U/kg or LMWH 100 U/kg sc twice daily; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Development of a Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
Brief Summary: Development of Real-Time Antiretroviral Therapy Adherence Intervention in Uganda (The Wisepill Study).


Options:
A: Arm Label: Crowdsourced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Crowdsourced materials | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: BEHAVIORAL; Name: Crowdsourced materials; Assigned to Arm(s): Crowdsourced intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: EpxBreastfeeding, Other: Baby book survey | Arm Label: Control; Type: OTHER; Interventions: Other: Baby book survey | Intervention Type: OTHER; Name: EpxBreastfeeding; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Baby book survey; Assigned to Arm(s): Control, Intervention
C: Arm Label: ISAP SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ISAP SMS | Arm Label: No ISAP SMS; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ISAP SMS; Assigned to Arm(s): ISAP SMS
D: Arm Label: Fixed SMS, real-time monitoring; Type: EXPERIMENTAL; Interventions: Device: Fixed SMS, real-time monitoring | Arm Label: Triggered SMS, real-time monitoring; Type: EXPERIMENTAL; Interventions: Device: Triggered SMS, real-time monitoring | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Fixed SMS, real-time monitoring; Assigned to Arm(s): Fixed SMS, real-time monitoring | Intervention Type: DEVICE; Name: Triggered SMS, real-time monitoring; Assigned to Arm(s): Triggered SMS, real-time monitoring

Answer: D